General Laboratory Hazards

The page below is a sample from the LabCE course COVID-19: Basics and Biosafety Precautions. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about COVID-19: Basics and Biosafety Precautions (online CE course)
General Laboratory Hazards

Laboratories should routinely perform site-specific and activity-specific risk assessments with appropriate personnel and/or other professional safety partners to correctly identify and mitigate any identified hazards and safety risks. Risk assessments and mitigation measures will be dependent on significant factors such as:
  • Identification of the hazards involved in the laboratory processes or procedures.
  • Competency level of personnel who perform procedures.
  • Laboratory equipment and facility.
  • Resources available to the laboratory.
Examples of primary hazards commonly found in clinical laboratories include:
  • Handling, transporting, and manipulation of potentially infectious specimens.
  • Procedures that may generate aerosols (e.g., pipetting) or have the potential for spills or splashes to occur.
  • Exposure hazards from infectious materials to mucous membranes (eye, nose, mouth), ingestion, or inhalation routes.
  • Sharps, which may be contaminated with infectious material.
  • Performing test procedures outside of a containment device, such as on an open bench or with testing instruments that may have an open well system.
  • Chemical hazards associated with testing reagents, disinfectants, etc.
COVID-19 risk assessments should also consider the number of people that the laboratory space can realistically and safely accommodate while maintaining physical (social) distancing guidelines.
11. Gathany, J. (2020). "This image depicted a test tube with viral transport media that contained a patient’s sample to be tested for the presence of SARS-CoV-2, the virus that causes COVID-19." CDC.gov.https://phil.cdc.gov/Details.aspx?pid=23896

A test tube with viral transport media that contained a patient’s sample to be tested for the presence of SARS-CoV-2, the virus that causes COVID-19 (11).